STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

HSIC HENRY SCHEIN INCORPORATED StockScouter® Report

9

StockScouter® Score

HENRY SCHEIN INCORPORATED, a mid cap value company in the healthcare sector, is expected to outperform the market over the next six months with slightly less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The enterprise value-to-sales ratio is much lower than the average for comparably-sized companies in the StockScouter universe. Very Positive
  • Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
  • The most recent quarterly earnings report higher than analysts’ consensus forecast. Positive

 

Concerns

  • The ratio of HSIC’s forward price-to-earnings multiple to its estimated growth rate is well above the average of comparably-sized companies in the StockScouter universe. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be in favor, value stocks will be in favor, and healthcare stocks will be in favor.

Expected Risk/Return

Progress: 40% done.
Progress: 100% done.
Low
High

Core Model Grades

A
C
B
C

Previous Ratings

7
9
7